Delivery Order SPE2DB22D3010-SPE2DB25FP2PL

Award Date 5/28/25
Potential Completion Date 5/29/25
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,601.43 firm-fixed-price contract is for the delivery of FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML, a medication used in the treatment of osteoporosis. The contract has an ultimate completion date of June 24, 2025 and is not set aside for a specific business category. AmerisourceBergen Drug Corp holds a significant...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,728.88 contract is for the supply of the medication FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML. The contract has an ultimate completion date of July 1, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated...
This is a firm fixed-price delivery order for $15,352.68 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML. The contract has an ultimate completion date of May 23, 2025 and is not set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support...
This is a $31,034.42 firm fixed-price delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a medication used in the treatment of osteoporosis. The award has a period of performance through March 8, 2024. There is no set-aside designation, indicating this was an open competition. AmerisourceBergen holds a...
This is a $17,182.42 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide the medication FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML. The delivery order has an ultimate completion date of June 23, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to supply a wide range of pharmaceutical and medical products to...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,176.29, is for the supply of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a specialty medication. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is July 29, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
The U.S. Defense Logistics Agency (DLA) awarded a $1,833.32 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp., a major pharmaceutical distributor, for the supply of 4567733697 - FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML. The contract has an ultimate completion date of March 31, 2025 and was not set aside for any specific business type. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,893.04, is for the supply of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a medication used in the treatment of osteoporosis. The contract has a firm fixed price pricing type and an ultimate completion date of February 26, 2025. This delivery order is part of a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,440.46 firm fixed-price delivery order is for the supply of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a specialty medication. The contract has an ultimate completion date of October 24, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a specialty medication, with a ceiling value of $8,666.46. The contract has an ultimate completion date of May 23, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
  • SPE2DB22D3010
    Indefinite Delivery Contract
  • SPE2DB22D3010-SPE2DB25FP2PL
    Delivery Order

This is a $14,507.25 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML, a medication used to treat osteoporosis. The contract has an ultimate completion date of May 29, 2025 and is not a set-aside contract.

AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 8/27/25, 9:45 AM